WHO Determines DRC Bundibugyo Virus Outbreak Remains Public Health Emergency of International Concern

The World Health Organization determined on Tuesday that the Ebola disease outbreak caused by Bundibugyo virus in the Democratic Republic of the Congo remains a public health emergency of international concern, as cases surpass 11,600 with a crude fatality ratio near 49%.

Director-General Tedros Adhanom Ghebreyesus accepted the advice of the International Health Regulations Emergency Committee following its third meeting on 17 November, WHO said in its latest Disease Outbreak News. The decision reflects sustained, high-level transmission across eight DRC provinces despite a six-month response scale-up, with insecurity cited as the greatest obstacle to containment. Updated temporary recommendations for the DRC and all States Parties are expected in the coming days.

“The next phase must prioritize quality, reach and community trust, alongside sustained funding, coordination and security to save lives and end the outbreak,” WHO said in the 20 November update. The outbreak has now spread to 68 health zones, with active transmission in 48 of them as of 17 November.

DRC toll climbs as community deaths signal detection gaps

Since the previous Disease Outbreak News on 6 November, the DRC has recorded an additional 945 confirmed cases and 480 deaths, bringing cumulative totals to 11,613 cases and 5,678 deaths, WHO reported. The crude case fatality ratio stands at 48.9%, consistent with historical BVD outbreaks that ranged from 30% to 50%.

Ituri province remains the epicenter with 7,858 cumulative cases and 3,715 deaths (CFR 47%), while Nord Kivu reports the highest provincial CFR at 55% (2,860 cases, 1,590 deaths).

A critical concern persists: of 720 deaths reported since 28 October, 452 occurred in communities rather than treatment centers. This high community mortality, especially among young children, shows failures in early case detection and timely access to care. UNICEF reported on 13 November that children account for 28% of confirmed cases (2,959) and 35% of deaths (1,737), with a 72% fatality rate among confirmed cases in children under five, based on data through 4 November.

No Licensed Vaccine or Treatment Exists

  • No licensed vaccine or specific treatment exists for Bundibugyo virus; containment relies entirely on finding cases early, isolating patients, tracing contacts, and safe burials.
  • Kenya and Nigeria have contained imported clusters and are counting down 42 days with no new cases to declare their outbreaks over.

Contact Tracing Falls Short of Benchmark

As of 17 November, Nord Kivu averaged 77% (12,313 of 16,015 contacts seen daily), Tshopo 68%, Ituri 86%, Haut-Uélé 86%, and Sud-Ubangi 63%. Only Bas-Uélé (100%) and Nord-Ubangi (99%) met the target.

“Strengthened contact follow-up is required, particularly in provinces below the target, to achieve the minimum threshold of 95%,” WHO emphasized. Insecurity and population displacement continue to hamper surveillance teams’ access to affected communities.

Imported clusters contained in Kenya and Nigeria; EU risk assessed as very low

Kenya has reported nine confirmed cases and two deaths, all linked to a single imported index case who traveled from DRC via Uganda. Eight secondary cases — four family members and four healthcare workers — were already under quarantine when symptoms developed. The last patient was discharged on 11 November, and all 135 identified contacts have completed 21-day follow-up. A 42-day countdown to declare the end of the outbreak is underway.

Nigeria reported one imported case on 20 October in a traveler who arrived from Uganda via Addis Ababa on 3 October, developed symptoms on 7 October, and sought care in Abuja on 11 October. The patient and a close contact were medically evacuated to Switzerland on 26 October; the patient recovered and was discharged on 11 November after two negative PCR tests. All 62 contacts in Nigeria completed 21-day follow-up by 13 November.

The European Centre for Disease Prevention and Control assesses the risk of BVD importation to the EU/EEA as very low, citing the small number of expected cases. ECDC does not recommend travel restrictions or entry screening for travelers from Kenya or Nigeria, noting entry screening is not proven efficient for detecting imported cases. France, Germany, and the Netherlands have managed medically evacuated cases without secondary transmission.

No licensed vaccines or therapeutics for Bundibugyo virus

Unlike Zaire ebolavirus (EBOV), for which Ervebo (rVSV-ZEBOV) and Mvabea/Zabdeno vaccines are licensed, no approved vaccines or specific antiviral treatments exist for Bundibugyo virus disease. Outbreak control depends on non-pharmaceutical interventions: rapid case identification, isolation, supportive care, contact tracing, infection prevention and control in health facilities, safe burials, and community engagement.

Clinical differentiation from endemic febrile illnesses like malaria requires laboratory confirmation, complicating early detection in resource-constrained settings.

Province Cumulative Cases Cumulative Deaths Case Fatality Ratio Health Zones Affected
Ituri 7,946 3,751 47% 28 of 36
Nord Kivu 2,996 1,654 55% 17 of 34
Haut-Uélé 534 231 47% 8 of 13
Tshopo 109 35 — 7 of 23
Other provinces 28 7 — 8 zones

Contraindications & When to Seek Care

Bundibugyo virus disease is not endemic outside sub-Saharan Africa. Travelers returning from affected areas in DRC, Kenya, or Nigeria who develop sudden fever, fatigue, muscle pain, headache, or sore throat within 21 days of return should seek immediate medical evaluation and disclose travel history.

Healthcare workers evaluating such patients must implement strict contact and droplet precautions pending laboratory confirmation. Early supportive care — fluid resuscitation, electrolyte management, and treatment of secondary infections — improves survival, but no specific antiviral is approved for BVD.

Democratic Republic of the Congo, the second-largest country in Africa by land area and the fourth-most populous with about 116 million people, centers on the Congo Basin where dense rainforests and many rivers dominate the terrain.

The east and southeast are mountainous, and over 120 armed groups remain active there, concentrated in provinces such as Ituri and Nord Kivu that now form the outbreak’s epicenter. Decades of conflict have displaced 7 million people and left around one million Congolese refugees in neighboring countries as of 2022, while the country ranked 171 out of 193 on the Human Development Index in 2023.

The Emergency Committee will reconvene in three months or sooner if the situation changes significantly. WHO said updated temporary recommendations will be issued in the coming days and reported in the next Disease Outbreak News publication.

References

  • World Health Organization. Disease Outbreak News: Ebola disease caused by Bundibugyo virus – Democratic Republic of the Congo, Kenya and Nigeria. 20 November 2026.
  • European Centre for Disease Prevention and Control. Ebola disease outbreak caused by Bundibugyo virus – Multi-country – 2026. EpiPulse Event 2141. 15 November 2026.
  • European Centre for Disease Prevention and Control. Importation of Ebola disease cases caused by Bundibugyo virus to Kenya and Nigeria. Threat Assessment Brief. 23 October 2026.
  • UNICEF. Fast facts: Ebola outbreak toll on children six months into the response. 13 November 2026.
  • Nigeria Centre for Disease Control. Ebola disease outbreak in Nigeria. 14 November 2026.

Photo of author

Health Desk

Health Desk at Archyde.

Stuff: Trump, Xi, Putin Meet in Shenzhen for Trilateral Summit